Studies using similar protocols have reduced opioid consumption by 30-40% after knee or hip replacement. By closing the gate preemptively (pre-incisional stimulation), central sensitization is minimized.

Let’s break down why this matters for sedation providers—especially in a dental or minor procedure setting.

Preclinical studies have demonstrated that DDSC-018 can effectively reduce pain in various animal models of pain, including inflammatory, neuropathic, and cancer pain. These findings have led to the initiation of clinical trials to evaluate the safety and efficacy of DDSC-018 in humans.

Pain Gate Ddsc 018 File

Studies using similar protocols have reduced opioid consumption by 30-40% after knee or hip replacement. By closing the gate preemptively (pre-incisional stimulation), central sensitization is minimized.

Let’s break down why this matters for sedation providers—especially in a dental or minor procedure setting.

Preclinical studies have demonstrated that DDSC-018 can effectively reduce pain in various animal models of pain, including inflammatory, neuropathic, and cancer pain. These findings have led to the initiation of clinical trials to evaluate the safety and efficacy of DDSC-018 in humans.